PEER Online® is a clinical decision support database that uses a combination of software, analytics, and clinical outcomes to provide objective, adjunctive medication response information to physicians treating patients with non-psychotic behavioral disorders. PEER Reports™ represent the output of the Psychiatric Electroencephalography Evaluation Registry (PEER), an outcome registry developed by physicians in order to build better evidence for prescribing in brain disorders.
PEER Online uses a statistical analysis of EEG outputs and other patient information to generate a report that indicates the statistical likelihood of the patient’s responsiveness to classes of central nervous system (CNS) medications (i.e. antidepressants), groups (i.e. SSRI) and individual agents (i.e. fluoxetine). A discriminant analysis compares neurophysiologic abnormalities of the patient to patterns of abnormalities of known responders to CNS drugs in the company’s outcomes database of symptomatic patients. This provides a probability estimate of the similarity of the patient’s profile with the profile of groups of individuals constituting the normative and clinical (symptomatic) database, which provides the treating physician guidance to which treatments the patient will most likely respond to, and those treatments to which the patient is least likely to respond. This is adjunctive information, to be interpreted only within the context of the overall clinical assessment of the patient by the attending physician.